AltiBio, Inc. is a biopharmaceutical company based in Half Moon Bay, CA, dedicated to bringing relief to individuals living with rare and severe diseases. Founded in 2017 by a team with a successful track record in developing and commercializing orphan therapeutics, AltiBio is focused on developing therapies that make a meaningful impact on patients' lives. With several projects in development for undisclosed rare diseases, the company has a strong foundation of expertise and compelling data supporting its lead candidate.
Driven by powerful experiences, such as a heartfelt encounter with a grateful patient, AltiBio's mission is to develop therapies that bring relief to those in need. With a history of favorable clinical, regulatory, and commercial outcomes, the company is now seeking Series B funding to advance its lead candidate through Phase 1 of development. AltiBio's dedication to improving the lives of individuals with rare diseases sets it apart as a promising player in the biopharmaceutical industry.
Generated from the website